Overview

Red Blood Cell ATP Release and Vascular Function in Humans

Status:
Completed
Trial end date:
2018-10-05
Target enrollment:
Participant gender:
Summary
Previous work demonstrates that the red blood cells of older adults do not release a potent vasodilator (ATP) as well as the red blood cells of younger adults. The investigators are targeting a pathway within the red blood cell using fasudil hydrochloride to determine if both the release of ATP from red blood cells and blood flow responses to low oxygen (hypoxia) and exercise in older adults can be improved.
Phase:
Phase 2
Details
Lead Sponsor:
Colorado State University
Treatments:
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Fasudil